ScorePulmonology
GAP index and stage (idiopathic pulmonary fibrosis)
Estimates 1-, 2- and 3-year mortality in idiopathic pulmonary fibrosis from sex, age and lung function.
Updated 31 October 2026
When to use it
Patients with idiopathic pulmonary fibrosis, at diagnosis or follow-up, to stage disease and guide transplant referral.
What it needs
- Sex
- Age
- FVC (% predicted)
- Unable to perform DLCO because of disease
- DLCO (% predicted)
The points for each answer and the automatic total are in the app.
How to interpret it
| Result | Interpretation |
|---|---|
| ≤ 3 | Stage I: mortality ≈ 6 % at 1 year, 11 % at 2 years and 16 % at 3 years |
| 4–5 | Stage II: mortality ≈ 16 % at 1 year, 30 % at 2 years and 42 % at 3 years |
| ≥ 6 | Stage III: mortality ≈ 39 % at 1 year, 62 % at 2 years and 77 % at 3 years |
Practical tip
It only uses routine data (sex, age, FVC and DLCO), so it can be applied in any clinic.
2 more practical tips in the app.
Reference
A support tool for healthcare professionals: it guides and does not replace clinical judgement.
